Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Clinical Ultrasound"
DOI: 10.1002/jcu.23240
Abstract: Portopulmonary hypertension (POPH) is characterized by portal hypertension leading to splanchnic vasodilatation and formation of portosystemic shunts. These phenomena contribute directly to a decrease in peripheral vascular resistance, which is exacerbated by vasoactive substances able… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Annals of vascular surgery"
DOI: 10.1016/j.avsg.2018.12.078
Abstract: Portopulmonary hypertension (PoPH) is a well-recognized complication of portal hypertension. This study reports a case of PoPH that was secondarily caused by post-traumatic mesenteric arteriovenous fistula. A 38-year-old man with a history of knife stabbing… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2020.02.021
Abstract: BACKGROUND & AIMS Long-term outcomes in portopulmonary hypertension (PoPH) are poorly studied in the current management era of pulmonary hypertension. We analysed the effect of pulmonary arterial hypertension (PAH)-targeted therapies, the survival and the predictors… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Transplantation Direct"
DOI: 10.1097/txd.0000000000001162
Abstract: Background. The causes and circumstances surrounding death are poorly studied in patients with portopulmonary hypertension (PoPH). We sought to determine the specific reasons for dying and characteristics surrounding this process in patients with PoPH. Methods.… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Hepatology Research"
DOI: 10.1111/hepr.13735
Abstract: This study aimed to demonstrate the feasibility of identifying candidates of portopulmonary hypertension (PoPH) from general portal hypertension patients based on chest computed tomography (CT) results. read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "BMC Pulmonary Medicine"
DOI: 10.1186/s12890-021-01452-3
Abstract: Background Portopulmonary hypertension (PoPH) refers to the simultaneous presentation of pulmonary arterial and portal hypertension. However, few reports have included the characteristics and treatments for patients with PoPH of Asian population; thus, we investigated the… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0267125
Abstract: Aim Portopulmonary hypertension (PoPH) is a rare and serious complication of liver cirrhosis and portal hypertension that can interfere with liver transplantation (LT). We evaluated the prevalence of PoPH and the clinical features of right… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Bosnian journal of basic medical sciences"
DOI: 10.17305/bjbms.2017.2020
Abstract: Hepatopulmonary syndrome (HPS) is a severe complication of advanced liver disease associated with an extremely poor prognosis. HPS is diagnosed in 4-47% of patients with cirrhosis and in 15-20% of candidates for liver transplantation. In… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "International Journal of General Medicine"
DOI: 10.2147/ijgm.s339474
Abstract: Purpose Metabolic parameters are important for the development of portopulmonary hypertension (PoPH) during nonalcoholic steatohepatitis (NASH)-associated cirrhosis. This study evaluated patients with NASH-associated cirrhosis to determine metabolic risk factors for portopulmonary hypertension. Patients and Methods… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2023.1142836
Abstract: Portopulmonary hypertension (PoPH) is a rare subtype of Group 1 pulmonary arterial hypertension (PAH) with a poor prognosis. According to the most up-to-date definition, PoPH is characterized by a mean pulmonary arterial pressure (PAP) of… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Medicina"
DOI: 10.3390/medicina58101484
Abstract: Background. Congenital absence of the portal vein (CAPV) is an extremely rare malformation that is caused by aberrant venous development during embryogenesis and is usually associated with congenital portosystemic shunts (CPSS). This hemodynamic allows mesenteric… read more here.